Skip to content

Clinical trials

Central Nervous System Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Country / region: South Korea Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20111
20122
20141
20161
20172
20183
20202
20222
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated6
Recruiting4
Unknown status3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
GlaxoSmithKline2
Hanyang University Seoul Hospital2
AbbVie1
Advanced Technology & Communications1
Bayer1
Chong Kun Dang Pharmaceutical1
Duk Lyul Na1
Eli Lilly and Company1
Guerbet1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases20
Brain Diseases15
Nervous System Diseases13
Alzheimer Disease11
Dementia11
Mental Disorders10
Neurodegenerative Diseases10
Neurocognitive Disorders7
Tauopathies7
Amyotrophic Lateral Sclerosis2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.